What is Jecho Laboratories?
Founded in 2013 and headquartered in Frederick, Maryland, Jecho Laboratories operates as a specialized research and development entity dedicated to the engineering of therapeutic biologics. The company maintains a diverse portfolio that encompasses advanced antibodies, cytokines, and oncolytic viruses. By focusing on high-impact biological molecules, Jecho Laboratories has established itself as a key innovator within the Maryland life sciences corridor. Their operational philosophy integrates rigorous scientific inquiry with a commitment to organizational diversity, positioning the firm as both a top-tier employer and a formidable player in the competitive landscape of modern medicine.
How much funding has Jecho Laboratories raised?
Jecho Laboratories has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Jecho Laboratories
PPP
Public-Private Partnership
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Jecho Laboratories?
With the successful closure of this major strategic investment, Jecho Laboratories is well-positioned to transition into a more aggressive phase of clinical development and commercial scaling. The capital will likely be deployed to expand the company's proprietary platform technologies and accelerate the progression of its lead candidates through the regulatory pipeline. As the firm matures, the focus will shift toward optimizing manufacturing processes and forging strategic partnerships to bring its therapeutic biologics to market. This late-stage funding trajectory suggests that Jecho is preparing for significant milestones in its product lifecycle, potentially including expanded clinical trials and increased market penetration in the global oncology and infectious disease sectors.
See full Jecho Laboratories company page
